Blunt Hopes Idea of Swift End to Zika Debate Will Bring House GOP on Board

The top Senate Republican health care appropriator, who is expected to play a key role in Zika conference negotiations, hopes the carrot of finishing talks on how to fund the fight to combat the virus will bring House Republicans on board with the Senate’s bill.

Sen. Roy Blunt (R-Mo.) said Thursday he thought it would be possible to convince House Republicans to agree to the Senate’s $1.1 billion legislation, in part because it would settle the question of how to fund the fight against Zika, a topic of discussion on Capitol Hill for the past four months. And the Senate bill comes with the added bonus of funding that fight until September 2017.

“The difference in the two numbers is their number only went through September the 30th of this year, and our number goes through Sept. 30 of next year,” Blunt said. “I’m hopeful that everybody will decide it’s better to deal with this right now rather than continue to deal with it for the rest of the summer.”

The Senate voted Wednesday to go to a conference committee on the issue. That chamber’s legislation includes $1.1 billion, not offset, for Zika. The House approved a bill with $622 million, with offsets.

Rep. Tom Cole (R-Okla.), who is one of the House conferees on the legislation, expects to unveil the House’s Labor-Health and Human Services funding bill later this month, which will include funding for the Zika virus to be spent during fiscal 2017.

He argues that if the House can pass that bill, Congress could still advance funding for Zika through the regular appropriations process. House Republicans have maintained that is the best way to move forward.

“If we actually pass the Labor-H bill or have an omnibus in a timely fashion, then there will be plenty of money available,” Cole said.

Cole declined to say how much funding for Zika will be included in the House Labor-HHS bill, but said the subcommittee had settled on a number and that it would be “hundreds of millions of dollars.” The Appropriations Subcommittee on State, Foreign Operations and Related Programs will also include funding for Zika in their fiscal 2017 funding bill, Cole said.

That, combined with the $622 million the House has already approved, would add up to roughly the amount of the Senate package, he said.

“We’re not very far apart,” he said. “This is actually more a debate about how you would finance what you know you need to do, than it is about anything else.”

Whether or not to offset the funds will surely be one of the primary debates of the conference committee, both Blunt and Cole acknowledged.

When asked whether Senate Republicans would be on board with offsets, Blunt said it was something they would have to work out. Cole said it was hard to say where negotiations on that issue stood, but that House members and Senators haven’t talked much about those details.

“We were busy doing the same thing,” he said. “Now you just have to sit down and figure out where there’s overlap, where there’s points of agreement.”

Briefings

Health Brief: GOP Senators Ask CBO to Fast-Track ACA Overhaul Review

Senate Republican leaders have asked the Congressional Budget Office to fast-track consideration of a plan from Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) to overhaul the Affordable Care Act. The CBO is reportedly in the process of analyzing the cost and coverage impact of the plan, as Republicans face pressure to make one last attempt at undoing the ACA before GOP senators’ ability to pass legislation with a simple majority expires on Sept. 30.

Health Brief: Week in Review & What’s Ahead

HELP Committee Chairman Lamar Alexander (R-Tenn.) hopes to reach a deal with Democrats on a plan to shore up the ACA exchanges early this week. A final agreement, if reached, is likely to extend key insurer payments, known as cost-sharing reductions, and include reforms to make it easier for states to establish reinsurance programs. Some Republicans are also pushing to give states more flexibility over required benefits in Obamacare plans, a proposal that is controversial with Democrats.

Health Brief: Some Moderate House Democrats Seek ACA Stabilization

While progressives this week rallied behind Sen. Bernie Sanders’ (I-Vt.) single-payer health care bill, a group of moderate House Democrats in the New Democrat Coalition aligned themselves with the Senate Health, Education, Labor and Pensions Committee’s bipartisan push to stabilize the Affordable Care Act exchanges, which Committee Chairman Lamar Alexander (R-Tenn.) aims to reach a final deal on by early next week.

Health Brief: Deal Reached to Extend CHIP Funding

Senate Finance Committee leaders reached a deal on a five-year reauthorization of the Children’s Health Insurance Program, in a win for children’s health advocates who are seeking longer-term funding certainty for the program, which will expire at the end of the month without congressional action. The deal also gradually phases out the enhanced federal share of funding for state CHIP programs, which was increased under the Affordable Care Act by 23 percentage points.

Health Brief: Some Navigators Shut Down Ahead of ACA Enrollment Period

Several navigator organizations, including one that received the largest federal grant for Obamacare enrollment activities in 2016, are suspending operations ahead of the 2018 open enrollment season because they haven’t received contracts for funding from the Department of Health and Human Services, which could cause enrollment to plummet. The Trump administration announced plans last month to cut funding for navigator groups by about 40 percent, but health officials haven’t said whether the grants would end altogether.

Health Brief: Teva Names New CEO

H. Lundbeck A/S’s Kaare Schultz was named as Teva Pharmaceutical Industries Ltd.’s new chief executive officer, ending a seven-month search by the world’s largest generic drug maker to find a new leader. Schultz could face pressure to split the company into two businesses, one focusing on patented specialty drugs and the other on cheap copycat medicines

Load More